ACTU
Actuate Therapeutics
ACTU
ACTU
19 hedge funds and large institutions have $80.5M invested in Actuate Therapeutics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
49.84% more ownership
Funds ownership: 1.96% → 51.8% (+50%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$440K | |
| 2 | +$130K | |
| 3 | +$128K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 5 |
Goldman Sachs
New York
|
+$89.6K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$931K | |
| 3 | -$232K | |
| 4 |
Citigroup
New York
|
-$87.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$25.3K |